03/22/2026
Where the Confusion Comes From
Much of the current confusion stems from misaligned or overly broad statements circulating in the market. Exosomes are often incorrectly described as drugs in all contexts, with claims that they must always carry a DIN or NPN, or that topical use is prohibited.
These statements do not accurately reflect Health Canada’s cosmetic framework when it comes to non-human-derived, topical cosmetic products that make appearance-based claims only.
Read to understand that Marketing Language Matters
Under Health Canada regulations, claims determine classification. When marketing cosmetic exosomes, providers must use language that reflects appearance, not physiology.
Get more from THMA - National Training and Mentoring Academy for Aesthetic Medicine on Patreon